Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $178.86 USD
Change Today -0.96 / -0.53%
Volume 1.5M
ALXN On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David L. Hallal

Chief Executive Officer and Director,Alexion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. David L. Hallal has been the Chief Executive Officer of Alexion Pharmaceuticals, Inc. since April 1, 2015. Mr. Hallal served as the Chief Operating Officer of Alexion Pharmaceuticals, Inc. from September 2014 to April 1, 2015. Mr. Hallal served as the Chief Commercial Officer and Executive Vice President of Alexion Pharmaceuticals, Inc. from October 2012 to September 2014. Mr. Hallal served as Senior Vice President of Global Commercial Operations at Alexion Pharmaceuticals, ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*

Chief Executive Officer and Director


The University of New Hampshire, Durham

Other Affiliations*

Annual Compensation*

Total Annual Compensation$696,058

Stock Options*

Restricted Stock Awards$3,268,430
All Other Compensation$17,500
Exercised Options30,000
Exercised Options Value$5,088,456
Exercisable Options262,960
Exercisable Options Value$35,552,500
Unexercisable Options120,576
Unexercisable Options Value$7,593,962
Total Value of Options$48,234,917
Total Number of Options413,536

Total Compensation*

Total Annual Cash Compensation$1,505,558
Total Short Term Compensation$696,058
Other Long Term Compensation$3,285,930
Total Calculated Compensation$7,514,608
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $178.86 USD -0.96


Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
Stephen Edward Foots Group Chief Executive, Executive Director, Chairman of Group Executive Committee, Member of Nomination Committee, Member of Routine Business Committee, Member of Group Safety, Health & Environment Steering Committee, Member of Finance Committee and Member of Risk Management Committee
Croda International plc
600.0K GBP
Heinz-Jurgen Bertram Ph.D.Chairman of Executive Board, Chief Executive Officer and Labour Director
Symrise AG
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Chief Executive Officer, Managing Director, Member of the Management Council, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee
Dr. Reddy's Laboratories Ltd.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at